Profound Medical (PROF) Amortization - Deferred Charges (2019 - 2022)
Profound Medical has reported Amortization - Deferred Charges over the past 4 years, most recently at $892000.0 for Q1 2022.
- For Q1 2022, Amortization - Deferred Charges fell 0.89% year-over-year to $892000.0; the TTM value through Mar 2022 reached $5.3 million, down 5.92%, while the annual FY2020 figure was $2.7 million, 1487.13% up from the prior year.
- Amortization - Deferred Charges for Q1 2022 was $892000.0 at Profound Medical, down from $900000.0 in the prior quarter.
- Over five years, Amortization - Deferred Charges peaked at $2.7 million in Q4 2020 and troughed at -$2.3 million in Q1 2020.
- A 4-year average of $629285.7 and a median of $892000.0 in 2022 define the central range for Amortization - Deferred Charges.
- Biggest five-year swings in Amortization - Deferred Charges: skyrocketed 1487.13% in 2020 and later decreased 0.89% in 2022.
- Year by year, Amortization - Deferred Charges stood at $171000.0 in 2019, then skyrocketed by 1487.13% to $2.7 million in 2020, then tumbled by 66.84% to $900000.0 in 2021, then fell by 0.89% to $892000.0 in 2022.
- Business Quant data shows Amortization - Deferred Charges for PROF at $892000.0 in Q1 2022, $900000.0 in Q1 2021, and $2.7 million in Q4 2020.